Diagnostic company LipoScience has begun the clinical development phase of a diagnostic test based on the gut flora metabolite, trimethylamine-N-oxide (TMAO). The nuclear magnetic resonance (NMR)-based TMAO assay is expected to detect ...
Tags: Liposcience, Clinical Development
Agilent Technologies has signed an agreement to supply its nuclear magnetic resonance (NMR) components for use in LipoScience's automated Vantera Clinical Analyzer. The FDA-cleared Vantera Clinical Analyzer combines proprietary ...
Tags: Agilent, NMR, clinical technology, clinical application